Pediatric meningosarcoma: Clinical evolution and genetic instability

Pediatric Neurology

Volumn 32, Issue 5, 2005, Pages 352-354

  López De Mesa, Reyes ^a   Sierrasesúmaga, Luis ^a   López De Cerain, Adela ^a   Calasanz, María José ^a   Patiño García, Ana ^a,b  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

^b UNIVERSITY OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN;

ARTICLE; BRAIN TUMOR; CARCINOMATOSIS; CASE REPORT; CHILD; CHROMOSOMAL INSTABILITY; CHROMOSOME 17P; CHROMOSOME ANALYSIS; CHROMOSOME DELETION; CLINICAL FEATURE; DISEASE EXACERBATION; FEMALE; GENE LOCUS; GENERAL CONDITION DETERIORATION; HUMAN; KARYOTYPE; LUNG METASTASIS; MENINX SARCOMA; MOLECULAR EVOLUTION; PRIORITY JOURNAL; SARCOMA; TUMOR GROWTH; TUMOR RESISTANCE; TUMOR SUPPRESSOR GENE;

EID: 18144362832     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pediatrneurol.2004.11.010     Document Type: Article

References (11)

1. G.F. Haddad, O. Al-Mefty Meningeal sarcomas A.H. Kaye E.R. Laws Brain tumors An encyclopedic approach 2001 Churchill Livingstone Toronto 713 724
2. W. Paulus, B.W. Scheithauer Mesenchymal, non-meningothelial tumours P. Kleihues W.K. Cavenee Pathology and genetics of tumours of the nervous system 2000 IARC Press Lyon 185 189
3. R.G. Weber, J. Boström, M. Wolter Analysis of genomic alterations in benign, atypical and anaplastic meningiomas Toward a genetic model of meningioma progression Proc Natl Acad Sci USA 94 1997 14719 14724
4. K. Lamszus, L. Kluwe, J. Matschke, H. Meissner, R. Laas, M. Westphal Allelic losses at 1p, 9q, 10q, 14q and 22q in the progression of aggressive meningiomas and undifferentiated meningeal sarcomas Cancer Genet Cytogenet 110 1999 103 110
5. R. Lopez de Mesa, A. Lopez de Cerain Salsamendi, L.S. Ariznabarreta, M.J. Calasanz Abinzano, A. Patino-Garcia Measurement and analysis of the chemotherapy-induced genetic instability in pediatric cancer patients Mutagenesis 17 2002 171 175
6. F. Mitelman ISCN. An international system for human cytogenetic nomenclature 1995 S. Karger Basel
7. M. Simon, A.J. Kokkino, R.E. Warnick, J.M. Tew, A. von Demling, A.G. Menon Role of genomic instability in meningioma progression Genes Chromosom Cancer 16 1996 265 269
8. P.H. Aguiar, C. Agner, R. Simm, A.B. Freitas, A.M. Tsanaclis, P. Plese p53 Protein expression in meningiomas--a clinicopathologic study of 55 patients Neurosurg Rev 25 2002 252 257
9. F.M. Verheijen, M. Sprong, J.M. Kloosterman, G. Blaauw, J.H. Thijssen, M.A. Blankenstein TP53 mutations in human meningiomas Int J Biol Markers 17 2002 42 48
10. Y. Kamei, M. Watanabe, T. Nakayama, K. Kanamaru, S. Waga, T. Shiraishi Prognostic significance of p53 and p21WAF1/CIP1 immunoreactivity and tumor micronecrosis for recurrence of meningiomas J Neurooncol 46 2000 205 213
11. S.A. Pai, M.C. Cheung, M.M. Romsdahl, A.S. Multani, S. Pathak Can genetic instability be studied at the single chromosome level in cancer cells? Evidence from human melanoma cells Cancer Genet Cytogenet 109 1999 51 57